Royalty Pharma Logo

Royalty Pharma

🇺🇸
RPRX
GB00BMVP7Y09

Royalty Pharma is a leading investor in medical innovation, headquartered in the US. The company acquires and finances vital medicines through long-term royalty and financing agreements. Through strategic partnerships, Royalty Pharma enables pharmaceutical companies to advance research and development, bringing life-changing therapies to patients globally.

Next Quarterly Earnings

Wednesday, November 11, 2026
CW 46
Pre-Market
In 76 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on October 14, 2026

Stock Price

Frequently asked questions

When will Royalty Pharma report its next quarterly earnings?

Royalty Pharma is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did Royalty Pharma last report quarterly earnings?

Royalty Pharma last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 1.32 USD.

How does Royalty Pharma stock react to earnings?

Across its last 5 earnings reports, Royalty Pharma stock moved by ±1.9% on average the following day. The largest reaction was +6.8% on 11/05/2025; 5 of 5 reactions were positive.

How often has Royalty Pharma beaten expectations?

Royalty Pharma has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).

How do I add the Royalty Pharma earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:$1.17
Actual:
Q2 2026
Beat
Estimate:$1.27
Actual:$1.32
Difference:+$0.05
Price reaction (1 day):+0.5 %
Price reaction (7 days):+3.0 %
Q1 2026
Beat
Estimate:$1.21
Actual:$1.30
Difference:+$0.08
Price reaction (1 day):+0.6 %
Price reaction (7 days):+5.6 %
Q4 2025
Beat
Estimate:$1.29
Actual:$1.47
Difference:+$0.18
Price reaction (1 day):+0.1 %
Price reaction (7 days):+2.6 %
Q3 2025
Beat
Estimate:$1.04
Actual:$1.17
Difference:+$0.13
Price reaction (1 day):+6.8 %
Price reaction (7 days):+4.6 %
Q1 2025
Beat
Estimate:$1.03
Actual:$1.14
Difference:+$0.11
Q4 2024
Estimate:
Actual:
Price reaction (1 day):+1.7 %
Price reaction (7 days):+3.6 %

Earnings statistics

Stock reaction to earnings

±1.9%
Avg. next-day move
+6.8%
Largest move (11/05/2025)
100%
Share of positive reactions
±3.9%
Avg. move after 7 days

Basis: price reactions to the last 5 report dates (close to close).

Estimates vs. results

5/5
Quarters above estimates
100%
Beat rate
+5%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Royalty Pharma
Ticker Symbol
RPRX
ISIN
GB00BMVP7Y09
Country
🇺🇸
USA
Sector
More Financial Information